Monte Rosa Therapeutics, Inc. (GLUE)

NMS – Real Time Price. Currency in USD

19.11

-1.15 (-5.68%)

At close: May 12, 2026, 4:00 PM EDT

18.98

-0.13 (-0.68%)

Pre-market: May 13, 2026, 6:07 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

124M

76M

Cost of goods sold

-8M

-6M

-9M

Gross Profit

115M

68M

-6M

-9M

Operating expenses (excl. COGS)

-170M

-149M

-137M

-104M

Operating Income

-54M

-81M

-143M

-112M

Non-operating income, total

14M

11M

Pretax income

-40M

-70M

-135M

-109M

Equity in earnings

Taxes

-3M

-338K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-39M

-73M

-135M

-109M

Monte Rosa Therapeutics, Inc. (GLUE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Monte Rosa Therapeutics, Inc. (GLUE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Monte Rosa Therapeutics, Inc. (GLUE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Monte Rosa Therapeutics, Inc. (GLUE)

Income Statement (Annual)

Income Statement (Annual)